Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.
Clinical trial NCT00334295 · COMPLETED
Trial details
- NCT number
- NCT00334295
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-12-01
- Primary completion
- 2011-01-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.